Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$927M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$430M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$382M |
| 5 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
+$306M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$507M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$430M |
| 4 |
iShares Russell Mid-Cap ETF
IWR
|
+$356M |
| 5 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.75% |
| 2 | Healthcare | 8.81% |
| 3 | Financials | 8.45% |
| 4 | Consumer Discretionary | 7.56% |
| 5 | Industrials | 7.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RIDE
4101
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $982K | ﹤0.01% |
8,208
+5,314
| +184% | +$552K |
|
4102
CRA International
CRAI
$1.06B
| $974K | ﹤0.01% |
9,802
+5,097
| +108% | +$460K |
|
4103
Aurora
AUR
$13.7B
| $973K | ﹤0.01% |
+97,953
| New | +$968K |
|
|
CRT
4104
Cross Timbers Royalty Trust
CRT
$59.5M
| $972K | ﹤0.01% |
69,201
+32,384
| +88% | +$398K |
|
|
INBX
4105
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $972K | ﹤0.01% |
29,189
+17,692
| +154% | +$538K |
|
4106
BancFirst
BANF
$3.77B
| $968K | ﹤0.01% |
16,091
-6,435
| -29% | -$368K |
|
4107
Futu Holdings
FUTU
$15.2B
| $968K | ﹤0.01% |
10,640
+3,104
| +41% | +$343K |
|
4108
Barron's 400 ETF
BFOR
$235M
| $967K | ﹤0.01% |
65,664
+1,236
| +2% | +$18.5K |
|
4109
Invesco MSCI Global Timber ETF
CUT
$33.6M
| $967K | ﹤0.01% |
26,757
-7,273
| -21% | -$276K |
|
4110
Zumiez
ZUMZ
$330M
| $965K | ﹤0.01% |
24,269
-17,002
| -41% | -$725K |
|
4111
CALL
Akamai
AKAM
$16.9B
| $963K | ﹤0.01% |
164,200
| – | – |
|
4112
Provident Financial Services
PFS
$3.17B
| $962K | ﹤0.01% |
40,972
+25,138
| +159% | +$555K |
|
4113
Standard BioTools
LAB
$310M
| $960K | ﹤0.01% |
145,618
+111,882
| +332% | +$736K |
|
4114
MediWound
MDWD
$178M
| $960K | ﹤0.01% |
41,063
+2,987
| +8% | +$79.7K |
|
|
KYNB
4115
Kyntra Bio
KYNB
$28.2M
| $957K | ﹤0.01% |
3,744
-672
| -15% | -$238K |
|
4116
Arlo Technologies
ARLO
$1.59B
| $953K | ﹤0.01% |
148,532
+55,650
| +60% | +$346K |
|
4117
Thryv Holdings
THRY
$95.5M
| $953K | ﹤0.01% |
+31,717
| New | +$995K |
|
4118
PIMCO Corporate & Income Opportunity Fund
PTY
$2.52B
| $951K | ﹤0.01% |
51,967
+1,853
| +4% | +$37K |
|
4119
Genius Sports
GENI
$2.1B
| $950K | ﹤0.01% |
50,915
+1,783
| +4% | +$32.6K |
|
|
NKLA
4120
DELISTED
Nikola Corporation Common Stock
NKLA
| $949K | ﹤0.01% |
2,965
-526
| -15% | -$184K |
|
4121
Invesco S&P 100 Equal Weight ETF
EQWL
$2.78B
| $948K | ﹤0.01% |
11,833
-1,650
| -12% | -$135K |
|
|
HEES
4122
DELISTED
H&E Equipment Services
HEES
| $945K | ﹤0.01% |
27,238
+3,343
| +14% | +$111K |
|
4123
PUT
Las Vegas Sands
LVS
$29.4B
| $944K | ﹤0.01% |
+25,800
| New | +$1.11M |
|
4124
Vista Gold
VGZ
$326M
| $944K | ﹤0.01% |
1,303,147
+531,253
| +69% | +$454K |
|
4125
Escalade
ESCA
$294M
| $943K | ﹤0.01% |
49,866
+21,004
| +73% | +$465K |
|
Similar funds
Wells Fargo's Q3 2021 Portfolio in Review
As of Q3 2021, Wells Fargo held 8,005 positions worth $455B, down 0.26% from $456B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Wells Fargo's Q3 2021 filing shows 478 new, 3,039 increased, 3,074 reduced and 321 closed positions. Its largest new stake was Blend Labs: 6,286,123 shares worth $84.7M. The largest sale was iShares Russell 2000 ETF, an estimated $1.03B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- Wells Fargo's largest Q3 2021 buy was Blend Labs: 6,286,123 shares worth $84.7M.
- Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $1.04B increase.
- Wells Fargo's biggest Q3 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $1.03B.
- Wells Fargo fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $166M.
- Wells Fargo's ten largest holdings make up 16% of its $455B portfolio in Q3 2021.
- Wells Fargo opened 478 new positions and closed 321 in Q3 2021.
- Wells Fargo's portfolio value fell 0.26% quarter-over-quarter to $455B.
Based on Wells Fargo's 13F filing for Q3 2021, filed 15 Nov 2021.